1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
High Sierra Technologies, Inc.

High Sierra Technologies, Inc.

HSTI
High Sierra Technologies, Inc.US flagOther OTC
1.40
USD
- -
- -
29.35MMarket Cap
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.02
-0.02
-0.02
-0.02
-0.03
-0.02
-0.03
- -
-0.02
-0.02
-0.02
-0.02
-0.02
Free Cash Flow per Basic Share
-0.01
-0.01
-0.01
-0.01
-0.01
-0.02
-0.01
-0.01
- -
-0.03
-0.01
-0.01
-0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.1
-0.11
-0.13
-0.15
-0.17
-0.2
-0.22
-0.25
- -
-0.01
-0.02
-0.02
-0.02
-0.04
Tangible Book Value per Share
-0.1
-0.11
-0.13
-0.15
-0.17
-0.2
-0.22
-0.25
- -
-0.01
-0.02
-0.02
-0.02
-0.04
Basic Weighted Avg Shares
2
2
2
2
2
2
2
2
- -
20
20
20
21
21
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
- -
1
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
31
35
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-25.23%
-64.75%
16.97%
Free Cash Flow
- -
- -
49.05%
Net Income, GAAP
- -
- -
2.37%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.06
- -
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Vincent C. Lombardi
Full Time Employees
3
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
1495 Ridgeview Drive Reno NV United States of America 89519
IPO Date
Sep 4, 2007
CIK
0001365388
Website
high-sierra.com
Similar Companies
Mallinckrodt plc (MNKPF)
Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
Maple Leaf Green World Inc. (MGW.CN)
Eton Pharmaceuticals, Inc. (ETON)
Valiant Laboratories Limited (VALIANTLAB.BO)
Guerbet S.A. (0ELV.L)
Business
High Sierra Technologies, Inc. (HSTI) develops and licenses proprietary patented technologies for producing low-odor cannabis and hemp products for the medical, recreational, and industrial sectors. The company's core offerings include low-odor cannabis and hemp suitable for smoking or as base materials for manufacturing flavored cannabis and hemp products such as menthol-infused variants, smokable hemp cigarettes, and related consumer goods including gummies; its intellectual property encompasses the plant material itself, production processes, and derivative products created using these technologies. HSTI markets its innovations under the Hush Puppy™ brand and holds multiple United States patents (Nos. 10,737,198; 10,835,839; 11,338,222), as well as corresponding patents in Canada (No. 3,031,123) and Europe (No. EP3743055). Founded in 1996 and headquartered in Reno, Nevada, the company operates primarily in North America, with licensing and marketing efforts focused on the United States cannabis market, including California, and potential expansion into Canada and Europe. In recent developments, HSTI announced its first U.S. patent licensing agreement in August 2025 with Seventh Wave, LLC for producing substantially low-odor marijuana products, marking the initial commercial utilization of its technologies in California's consumer marketplace. The company successfully launched its Hush Puppy™ branded low-odor marijuana cigarettes, expanding availability to 10 dispensaries across California by mid-2025 following a debut at the Hall of Flowers trade show in March 2025. Additional advancements include a November 2025 Issue Notification for a new U.S. patent and ongoing efforts to pair licensing with mandatory Hush Puppy™ branding through state-level trademarks.